| 注册
首页|期刊导航|天津中医药大学学报|基于CiteSpace的生脉类中成药治疗心血管疾病知识图谱可视化分析

基于CiteSpace的生脉类中成药治疗心血管疾病知识图谱可视化分析

季宏昌 黄湘龙 金鑫瑶 王佳宝 肖璐 闫景贤 李霄

天津中医药大学学报2025,Vol.44Issue(8):731-739,9.
天津中医药大学学报2025,Vol.44Issue(8):731-739,9.DOI:10.11656/j.issn.1673-9043.2025.08.09

基于CiteSpace的生脉类中成药治疗心血管疾病知识图谱可视化分析

Visualization analysis of knowledge map of Shengmai-based Chinese patent medicines in the treatment of cardiovascular diseases based on CiteSpace

季宏昌 1黄湘龙 2金鑫瑶 3王佳宝 2肖璐 1闫景贤 1李霄2

作者信息

  • 1. 天津中医药大学第一附属医院/国家中医针灸临床医学研究中心,天津 300381
  • 2. 天津中医药大学中医药研究院,天津 301617
  • 3. 天津中医药大学循证医学中心,天津 301617
  • 折叠

摘要

Abstract

[Objective]To investigate the current status of clinical and pharmacological research on Shengmai-based Chinese patent medicines for cardiovascular diseases,and to identify the hotspots,frontiers,and development trends in this field.[Methods]Relevant literature on Shengmai-based Chinese patent medicines for cardiovascular diseases was retrieved from the China National Knowledge Infrastructure(CNKI)database.Bibliometric analyses of authors,institutions,and keywords were conducted using CiteSpace software,and the distribution of intervention measures and outcome indicators was illustrated by bubble charts.[Results]A total of 665 articles were included.Among Shengmai-based medicines,Shengmai Injection had the highest number of related studies.These medicines were mainly applied to cardiovascular diseases such as heart failureand coronary heart disease.Outcome indicators primarily focused on clinical efficacy and cardiac function evaluation.[Conclusion]Comprehensive analysis reveals multiple core author groups in the research field of Shengmai-based Chinese patent medicines for cardiovascular diseases;however,cross-team collaboration remains insufficient.Enhanced cross-regional cooperation and communication are recommended.Keyword analysis demonstrates close integration between pharmacological and clinical research.Research topics primarily include disease-specific studies,integrated traditional Chinese and Western medicine therapies,mechanism exploration,and distribution of outcome indicators.Clinical efficacy remains the primary hotspot,whereas mechanism studies represented by myocardial apoptosis and cardiac protection effects of Shengmai-based medicines represent emerging hotspots and frontiers for future research.

关键词

生脉/心血管疾病/文献计量/进展分析

Key words

Shengmai/cardiovascular diseases/bibliometrics/research trends

分类

医药卫生

引用本文复制引用

季宏昌,黄湘龙,金鑫瑶,王佳宝,肖璐,闫景贤,李霄..基于CiteSpace的生脉类中成药治疗心血管疾病知识图谱可视化分析[J].天津中医药大学学报,2025,44(8):731-739,9.

基金项目

国家中医药管理局国医大师传承工作室建设项目 ()

天津市教委科研计划项目(2023KJ137) (2023KJ137)

天津中医药大学新教师科研启动项目(XJS2022209). (XJS2022209)

天津中医药大学学报

1673-9043

访问量0
|
下载量0
段落导航相关论文